Suppressive Effects of EGCG on Cervical Cancer
AbstractCervical cancer is the fourth most common gynecological cancer worldwide. Although prophylactic vaccination presents the most effective method for cervical cancer prevention, chemotherapy is still the primary invasive intervention. It is urgent to exploit low-toxic natural anticancer drugs on account of high cytotoxicity and side-effects of conventional agents. As a natural product, (-)-epigallocatechingallate (EGCG) has abilities in anti-proliferation, anti-metastasis and pro-apoptosis of cervical cancer cells. Moreover, EGCG also has pharmaceutical synergistic effects with conventional agents such as cisplatin (CDDP) and bleomycin (BLM). The underlying mechanisms of EGCG suppressive effects on cervical cancer are reviewed in this article. Further research directions and ambiguous results are also discussed. View Full-Text
Share & Cite This Article
Wang, Y.-Q.; Lu, J.-L.; Liang, Y.-R.; Li, Q.-S. Suppressive Effects of EGCG on Cervical Cancer. Molecules 2018, 23, 2334.
Wang Y-Q, Lu J-L, Liang Y-R, Li Q-S. Suppressive Effects of EGCG on Cervical Cancer. Molecules. 2018; 23(9):2334.Chicago/Turabian Style
Wang, Ying-Qi; Lu, Jian-Liang; Liang, Yue-Rong; Li, Qing-Sheng. 2018. "Suppressive Effects of EGCG on Cervical Cancer." Molecules 23, no. 9: 2334.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.